EASTGATE BIOTECH CORP: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2016)
- -$3.0M
- Total Assets (FY2016)
- $0
- Total Equity (FY2016)
- -$4.6M
- Cash Flows from Operating Activities (FY2016)
- -$389.5K
Source: EASTGATE BIOTECH CORP 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
